| Urooj Qazi, AUD | |
|
700 University Blvd, Galveston, TX 77550-5552 | |
| (409) 772-2711 | |
| Not Available |
| Full Name | Urooj Qazi |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 700 University Blvd, Galveston, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306512116 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 81282 (Texas) | Primary |
| Provider Name | Utmb Faculty Group Practice |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1942241146 PECOS PAC ID: 3375456734 Enrollment ID: O20031112000438 |
News Archive
The first international conference hosted by the University of South Florida College of Pharmacy will focus on ways to improve health care by customizing drug prescribing and treatment based on an individual's genetic makeup.
Impairment of oral intake occurs in the majority of patients with head and neck cancer (HNC) receiving chemoradiotherapy. Placement of prophylactic percutaneous endoscopic gastrostomy (PEG) tube in asymptomatic newly diagnosed HNC before chemoradiation is a common practice in some centers. In some studies, PEG has been associated with a decrease in treatment related weight loss in patients with HNC, but no studies have examined the utilization rate.
Oncologists have long puzzled over the fact that after cancer treatment, single cancer cells that are dispersed throughout the body - so-called disseminated tumor cells - are quick to grow and form secondary tumors called metastases in certain organs, while in other organs they metastasize more slowly, sometimes decades later. Such is the case with head and neck squamous cell carcinoma cells, which remain dormant when lodged in bone marrow but rapidly form tumors when they make their way into the lungs.
Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today its results for the third quarter and nine months ended July 31, 2010. Total revenues for the third quarter were $163.3 million or 0.7% lower than the same period last year. Excluding currency fluctuations, current year third quarter revenues would have increased by approximately 3.9% versus the same period last year.
› Verified 1 days ago
| Provider Name | Kelsey-seybold Medical Group, Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1013915255 PECOS PAC ID: 9739093527 Enrollment ID: O20031117000204 |
News Archive
The first international conference hosted by the University of South Florida College of Pharmacy will focus on ways to improve health care by customizing drug prescribing and treatment based on an individual's genetic makeup.
Impairment of oral intake occurs in the majority of patients with head and neck cancer (HNC) receiving chemoradiotherapy. Placement of prophylactic percutaneous endoscopic gastrostomy (PEG) tube in asymptomatic newly diagnosed HNC before chemoradiation is a common practice in some centers. In some studies, PEG has been associated with a decrease in treatment related weight loss in patients with HNC, but no studies have examined the utilization rate.
Oncologists have long puzzled over the fact that after cancer treatment, single cancer cells that are dispersed throughout the body - so-called disseminated tumor cells - are quick to grow and form secondary tumors called metastases in certain organs, while in other organs they metastasize more slowly, sometimes decades later. Such is the case with head and neck squamous cell carcinoma cells, which remain dormant when lodged in bone marrow but rapidly form tumors when they make their way into the lungs.
Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today its results for the third quarter and nine months ended July 31, 2010. Total revenues for the third quarter were $163.3 million or 0.7% lower than the same period last year. Excluding currency fluctuations, current year third quarter revenues would have increased by approximately 3.9% versus the same period last year.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Urooj Qazi, AUD 11511 Shadow Creek Pkwy, Pearland, TX 77584-7298 Ph: (713) 442-0000 | Urooj Qazi, AUD 700 University Blvd, Galveston, TX 77550-5552 Ph: (409) 772-2711 |
News Archive
The first international conference hosted by the University of South Florida College of Pharmacy will focus on ways to improve health care by customizing drug prescribing and treatment based on an individual's genetic makeup.
Impairment of oral intake occurs in the majority of patients with head and neck cancer (HNC) receiving chemoradiotherapy. Placement of prophylactic percutaneous endoscopic gastrostomy (PEG) tube in asymptomatic newly diagnosed HNC before chemoradiation is a common practice in some centers. In some studies, PEG has been associated with a decrease in treatment related weight loss in patients with HNC, but no studies have examined the utilization rate.
Oncologists have long puzzled over the fact that after cancer treatment, single cancer cells that are dispersed throughout the body - so-called disseminated tumor cells - are quick to grow and form secondary tumors called metastases in certain organs, while in other organs they metastasize more slowly, sometimes decades later. Such is the case with head and neck squamous cell carcinoma cells, which remain dormant when lodged in bone marrow but rapidly form tumors when they make their way into the lungs.
Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today its results for the third quarter and nine months ended July 31, 2010. Total revenues for the third quarter were $163.3 million or 0.7% lower than the same period last year. Excluding currency fluctuations, current year third quarter revenues would have increased by approximately 3.9% versus the same period last year.
› Verified 1 days ago
Julia Cote, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-2711 | |
Kimberly Boase, Audiologist Medicare: Medicare Enrolled Practice Location: 700 University Blvd, Galveston, TX 77550 Phone: 281-338-0829 | |
Dr. Joseph Ulysses Gajan Iv, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: University Of Texas Medical Br, 301 University Blvd., Galveston, TX 77555 Phone: 409-772-2711 Fax: 409-747-2185 | |
Mary Catherine Rincon, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 700 University Blvd, Galveston, TX 77550 Phone: 409-772-2711 | |
Bridget Catherine Meehan, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-2711 | |
Utmb Eci Launch Audiologist Medicare: Not Enrolled in Medicare Practice Location: 301 University Blvd, Rt 1022, Galveston, TX 77555 Phone: 409-772-2222 | |
Deborah Lynn Carlson, PHD Audiologist Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-2711 Fax: 409-747-2185 |